Product NDC: | 0555-0635 |
Proprietary Name: | Danazol |
Non Proprietary Name: | Danazol |
Active Ingredient(s): | 200 mg/1 & nbsp; Danazol |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0555-0635 |
Labeler Name: | Barr Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074582 |
Marketing Category: | ANDA |
Start Marketing Date: | 19960809 |
Package NDC: | 0555-0635-09 |
Package Description: | 60 CAPSULE in 1 BOTTLE (0555-0635-09) |
NDC Code | 0555-0635-09 |
Proprietary Name | Danazol |
Package Description | 60 CAPSULE in 1 BOTTLE (0555-0635-09) |
Product NDC | 0555-0635 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Danazol |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 19960809 |
Marketing Category Name | ANDA |
Labeler Name | Barr Laboratories Inc. |
Substance Name | DANAZOL |
Strength Number | 200 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] |